Developer docs
API playgroundTry for free, no card

Search company profiles

Automata

Full company profile

uuid00009ii

Namestring
Automata
Legal namestring
Automata Technologies Limited
Websiteurl
automata.tech
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Automata is a London-based, venture-backed lab automation company founded in 2015 (initially targeting general manufacturing before pivoting to life sciences) that sells the LINQ platform — a vertically integrated, software-defined lab automation system. The platform comprises three core modules: LINQ Bench, a modular robotic lab bench with over 800,000 configurable layouts, dual-access design, and Bridge/Maglev transport options that fits in the footprint of a standard lab bench; LINQ Cloud, a browser-based orchestrator providing workflow design, GitHub-synced version control, REST API integration, LIMS data exchange, and concurrent workflow execution; and LINQ Canvas, a node-based, no-code workflow design environment with hybrid static/dynamic scheduling and high-fidelity simulation. The stack is complemented by a Python SDK and MCP-enabled connectivity to AI models such as Claude, and is OEM-agnostic across third-party instruments (Agilent Bravo, Beckman Coulter, Molecular Devices, Multidrop, Certus Flex), enabling frictionless integration in mixed-vendor labs.

Automata sells primarily through a high-touch direct enterprise sales motion, with all commercial engagement initiated via a "Book a meeting" CTA, dedicated customer success managers, and multi-year quote-based contracts that bundle LINQ Bench hardware, LINQ Cloud SaaS subscriptions, professional services for bespoke workflow automation, and managed service-level support. The company is ISO 9001 certified, holds two pending UK patent applications (GB2615613 and GB2615525), and won the 2026 iF Design Award for the LINQ platform. Its customer base spans five top pharmaceutical companies (including AstraZeneca), biotech firms (bit.bio, CellVoyant, Valid, MaxWell Biosystems), NHS Trusts and clinical labs (Royal Marsden, HSL), academic and research institutions (Francis Crick Institute, Earlham Institute), CDMOs/CROs (Lonza, virology CROs running ELISA at scale), and public-sector organizations.

The company has raised approximately $135 million-plus across multiple rounds, including a $50M Series B in February 2022 led by Octopus Ventures, a $40M round in October 2023 led by Dimension with A.P. Moller Holding, and a $45M Series C in January 2026 led by Dimension with Danaher Ventures and a strategic investment partnership with Danaher Corporation — including integrations of LINQ into Molecular Devices and Beckman Coulter Life Sciences and a board seat for Danaher Ventures' Murali Venkatesan. A US presence has been built out through offices in Cambridge (Kendall Square) and Newton, MA, complementing the London UK headquarters, and the platform is now an ecosystem partner inside Benchling's Benchling Automation launch (May 2026).

Short descriptiontext

Automata is a London-based lab automation company selling the LINQ platform — vertically integrated modular robotic hardware, cloud orchestration software, and a no-code workflow designer — to pharmaceutical, biotech, NHS, academic, and CDMO/CRO customers to scale wet-lab throughput and enable AI-ready, closed-loop experimentation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
lab automation platform, robotic lab bench, workflow orchestration software, life sciences automation, AI-ready lab infrastructure
Industry4 codes
1End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
CodeHDAEANAAPrimaryYes
2AutoML & Low-Code ML Platform Operations
CodeHDAAABALPrimaryNo
3Model Development & Training Platforms (AutoML, Notebooks, Feature Stores)
CodeHDAEANABPrimaryNo
4Workflow Automation for IT & Ops (Runbooks, Job Scheduling)
CodeHDAEAHAHPrimaryNo
NAICS code2 codes
  • Computer Systems Design and Related Services54151
  • Computer Systems Design Services541512
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Integrated Systems Design7373
Product category
Lab Automation Platform
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1LINQ Bench hardware sales
TypeHardware Sales
Description

Sale and deployment of the proprietary modular robotic lab bench (LINQ Bench), a vertically integrated hardware product configurable to over 800,000 layouts. Sold as part of system deployments to life-sciences labs; underpins large capital sales engagements.

automata.tech
2LINQ Cloud software subscription
TypeSubscription Recurring
Description

Recurring software revenue from the cloud-based LINQ orchestrator, providing workflow design, scheduling, version control, REST API integration, LIMS data exchange, and real-time run management. Bundled with deployments and sold as ongoing SaaS to pharma, biotech, NHS, and academic customers.

automata.tech
3Service, support and customer success
TypeManaged Services
Description

"Dedicated customer success managers' guidance at every stage. Customer success, NOT customer support." Covers installation, integration with third-party instruments, training, and ongoing service-level agreements, including dedicated hardware and software SLAs.

automata.tech
4Custom integration and application development
TypeProfessional Services
Description

Professional services for bespoke workflow automation (e.g., deployment with the Francis Crick Institute's Advanced Sequencing Facility, "dedicated field application scientist and field application engineer working closely with laboratory scientists to optimise the deployment at every stage").

automata.tech
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Pricing details1 tier
1Quote-based, not publicly disclosed
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is custom per deployment; contact sales via "Book a meeting" CTA. No tier names or price points are disclosed publicly.

automata.tech
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1LINQ
Description

Automata's vertically integrated, software-defined lab automation platform comprising LINQ Bench (modular robotic lab bench hardware with over 800,000 configurable layouts), LINQ Cloud (cloud-based laboratory orchestration software), and LINQ Canvas (node-based workflow design tool with Python SDK).

automata.tech
Core offering1 text field

Automata sells the LINQ platform, a software-defined lab automation system combining modular robotic hardware (LINQ Bench with 800,000+ configurations), cloud-based orchestration software (LINQ Cloud), and a node-based workflow design tool (LINQ Canvas with Python SDK). The platform enables life-sciences labs to parallelize workflows, integrate OEM-agnostic third-party instruments, and connect AI models via MCP for closed-loop experimentation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 95.25% reduction in manual interactions in a UK genomic testing lab's library preparation workflow
+7 more records
Product overview1 text field

Automata offers a single unified lab automation platform called LINQ, structured as a platform-plus-modules architecture. The core LINQ platform is composed of three primary modules: LINQ Bench (proprietary configurable robotic hardware that fits in a standard lab bench footprint with over 800,000 customizable configurations), LINQ Cloud (cloud-based orchestration software with deep version control and remote access), and LINQ Canvas (node-based visual workflow design software requiring no coding). These modules are complemented by a Python SDK (developer experience tool that is seamlessly interchangeable with LINQ Canvas) and MCP-enabled connectivity to AI models. The platform is applied across three application verticals: Genomics (nucleic acid extraction, library prep, clinical genomics, quality control), Cell Biology (cell line development, media exchange, high-throughput screening, iPSC), and Assay & Screening (ELISA, cell-based assays). The platform is OEM-agnostic and integrates with existing lab instruments from multiple manufacturers, designed to be the operating system for AI-ready labs.

Product and service8 records
1LINQ Platform
CategoryCore platform
Description

A fully integrated, AI-ready lab automation platform that combines software, proprietary modular hardware, data availability, and an OEM-agnostic approach to enable modular configurations, higher throughputs, and parallel workflows for life-sciences labs.

2LINQ Bench
CategoryHardware module
Description

A configurable robotic lab bench that fits into the same footprint as a regular lab bench and supports any instrument with over 800,000 customizable configurations, including dual-access design and Bridge/Maglev transport options for seamless connections and high-speed transfers.

3LINQ Cloud
CategorySoftware module
Description

A cloud-based laboratory orchestrator that enables teams to build and test workflows as workcells process samples, with remote access, tags, runtime instructions, deep GitHub-synced version control, and the ability to run legacy versions on the latest platform.

4LINQ Canvas
CategorySoftware module
Description

A node-based workflow design software tool that lets scientists build complex experiments with no coding required, including High Fidelity Simulation, a Run Manager for real-time monitoring, and Process Canvas for full orchestration of multiple workflows simultaneously.

5LINQ Python SDK
CategoryDeveloper tool
Description

A Python software development kit that lets developers control every step of LINQ workflow automation from setup to simulation on a digital workcell, seamlessly interchangeable with LINQ Canvas for code-based or visual workflow design.

6Genomics Automation Solutions
CategoryApplication vertical
Description

Application-specific automation solutions for genomics workflows covering nucleic acid extraction, automated library prep, clinical genomics, and quality control, supporting diverse sample types with open chemistry compatibility.

7Cell Biology Automation Solutions
CategoryApplication vertical
Description

Application-specific automation solutions for cell biology workflows including cell line development and cryopreservation, media exchange, high-throughput screening, and iPSC cell culture, handling suspension cells, adherent cells, and organoids.

8Assay and Screening Automation Solutions
CategoryApplication vertical
Description

Application-specific automation solutions for assay and screening workflows including ELISA and cell-based assays, with vendor-agnostic integration, cloud-based workflow orchestration, and enhanced data traceability via automated barcode scanning.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierFlagship - Global Strategic PartnerTypeStrategic or Co-development Partner
Description

Global life sciences tools conglomerate. Entered a strategic investment partnership alongside the Series C that integrates Automata's software with Danaher's portfolio of instruments and reagents, including Molecular Devices and Beckman Coulter Life Sciences, to deliver end-to-end lab automation solutions.

Strategic tierFlagship - Strategic Integration PartnerTypeStrategic or Co-development Partner
Description

Subsidiary of Danaher. Strategic partnership to integrate Beckman Coulter's liquid handling, genomic and cell analysis technologies with Automata's LINQ AI-ready automation platform, enabling faster and more scalable experimentation. The collaboration coincides with Danaher Ventures' Series C participation and a board seat.

Strategic tierFlagship - Deep Technical IntegrationTypeTechnology or Integration
Description

Danaher subsidiary. Strategic collaboration announced 29 January 2026 to integrate Molecular Devices' microplate readers and high-content screening systems with Automata's LINQ platform, enabling lab instruments from different brands to communicate and move samples via software and robotics without human intervention.

Strategic tierCore - Ai Co-Development PartnerTypeStrategic or Co-development Partner
Description

AI biotech startup. Strategic partnership to deliver AI-powered closed-loop cell culture workflows by combining CellVoyant's AI with Automata's LINQ platform, making "adaptive cell culture an operational reality" (quote from CellVoyant Founder/CEO Rafael E. Carazo Salas).

Strategic tierFlagship - R&D PartnershipTypeStrategic or Co-development Partner
Description

Biomedical discovery institute. Announced 13 February 2023, Automata partners with the Crick's Advanced Sequencing Facility to automate three genomics workflows (amplicon library prep, FFPE RNA extraction, COVID-19 sequencing). The Crick enjoys early access to Automata demos and is a key stakeholder in product development.

Strategic tierFlagship - Flagship Clinical ReferenceTypeStrategic or Co-development Partner
Description

UK cancer centre. Partnership for a UK-first clinical diagnostics installation of Automata's robotic technology to "transform genomic testing at The Royal Marsden by streamlining our processes, substantially increasing our capacity without compromising accuracy" (Professor Michael Hubank, Scientific Director of Clinical Genomics).

Strategic tierCore - Ecosystem PartnerTypeTechnology or Integration
Description

Launched Benchling Automation on 28 May 2026 with ecosystem partners including HighRes, Automata, Ginkgo Bioworks, Celltrio, Opentrons, and Hamilton - a hardware-agnostic platform connecting lab instruments, workcells, and scientific records. Automata's LINQ workcells are callable from Benchling notebooks.

Strategic tierCore - Cell Biology Reference PartnerTypeStrategic or Co-development Partner
Description

Synthetic biology company. Listed as a partner/customer in Automata's "Trusted by our partners" logo strip and named in the 2023 $40m round press release.

Strategic tierCore - Genomics Reference PartnerTypeStrategic or Co-development Partner
Description

Genomics research institute. Partnership to "redefine lab automation" and "transform QC into a scalable genomics engine" (case study title on the website).

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Opentrons builds accessible benchtop lab robots (OT-2, Flex) with a Python API and a workflow/automation software stack, targeting biotech and academic labs with a similar modular, software-first ethos to Automata's LINQ. Listed alongside Automata as a Benchling Automation ecosystem partner, indicating direct overlap in customer use cases.

TypeDirect peer
Description

HighRes Biosolutions offers modular lab automation systems (Cellario software, modular robotic workstations) for pharma, biotech, and academic labs - the closest head-to-head competitor to Automata's LINQ Bench + LINQ Cloud platform. Co-listed with Automata in the Benchling Automation ecosystem.

TypeBroad incumbent
Description

Hamilton is a long-established leader in automated liquid handling workstations and lab robotics (Microlab STAR, VANTAGE) with a deep pharma/biotech installed base and integrated software. Competes with Automata on enterprise lab automation and is co-listed in the Benchling Automation ecosystem.

TypeBroad incumbent
Description

Tecan is a major incumbent in laboratory automation, offering liquid handling platforms, readers, and workflow software used across pharma, biotech, and diagnostics. Overlaps with Automata's genomics and cell biology workflows and has the scale to bundle software with its installed base.

TypeBroad incumbent
Description

Beckman Coulter Life Sciences (a Danaher subsidiary) provides liquid handlers, genomic and cell-analysis instruments that integrate with Automata's LINQ platform via a strategic partnership. It is both a distribution partner and a competitor in lab automation hardware.

TypeBroad incumbent
Description

Thermo Fisher offers the largest portfolio of life-sciences instruments and automation products (e.g., Orbitor, Spinnaker) along with software for lab workflows. Its scale, breadth, and service network represent the highest-end incumbent competition to Automata.

TypeBroad incumbent
Description

Agilent's Bravo liquid handler is explicitly integrated within Automata's open NGS library preparation workflows, and the company provides broader lab automation and analytical instruments. Comparable to Automata in genomics and analytical workflow automation.

TypeDirect peer
Description

Biosero offers Green Button Go, a laboratory automation scheduling and orchestration software that connects instruments, robots, and LIMS - directly comparable to LINQ Cloud's orchestration role, with a similar 'software over hardware' positioning.

9Celltrio
TypeEmerging player
Description

Celltrio provides cell-line development and cell therapy automation platforms (e.g., RoboQ, CellPicker) with software for closed-loop cell culture - a closely adjacent emerging player to Automata, particularly in the cell biology application vertical, and co-listed in Benchling Automation.

TypeOthers
Description

Ginkgo Bioworks operates large-scale automated synthetic biology foundries with proprietary software/hardware stacks for high-throughput organism engineering. While a buyer/integrator rather than direct vendor competitor, it is a comparable 'automated lab at scale' reference and is co-listed in Benchling Automation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration10 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors19 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Automata

Lab Automation Platformautomata.tech

Automata is a London-based lab automation company selling the LINQ platform — vertically integrated modular robotic hardware, cloud orchestration software, and a no-code workflow designer — to pharmaceutical, biotech, NHS, academic, and CDMO/CRO customers to scale wet-lab throughput and enable AI-ready, closed-loop experimentation.

What Automata does

Automata is a London-based, venture-backed lab automation company founded in 2015 (initially targeting general manufacturing before pivoting to life sciences) that sells the LINQ platform — a vertically integrated, software-defined lab automation system. The platform comprises three core modules: LINQ Bench, a modular robotic lab bench with over 800,000 configurable layouts, dual-access design, and Bridge/Maglev transport options that fits in the footprint of a standard lab bench; LINQ Cloud, a browser-based orchestrator providing workflow design, GitHub-synced version control, REST API integration, LIMS data exchange, and concurrent workflow execution; and LINQ Canvas, a node-based, no-code workflow design environment with hybrid static/dynamic scheduling and high-fidelity simulation. The stack is complemented by a Python SDK and MCP-enabled connectivity to AI models such as Claude, and is OEM-agnostic across third-party instruments (Agilent Bravo, Beckman Coulter, Molecular Devices, Multidrop, Certus Flex), enabling frictionless integration in mixed-vendor labs.

Automata sells primarily through a high-touch direct enterprise sales motion, with all commercial engagement initiated via a "Book a meeting" CTA, dedicated customer success managers, and multi-year quote-based contracts that bundle LINQ Bench hardware, LINQ Cloud SaaS subscriptions, professional services for bespoke workflow automation, and managed service-level support. The company is ISO 9001 certified, holds two pending UK patent applications (GB2615613 and GB2615525), and won the 2026 iF Design Award for the LINQ platform. Its customer base spans five top pharmaceutical companies (including AstraZeneca), biotech firms (bit.bio, CellVoyant, Valid, MaxWell Biosystems), NHS Trusts and clinical labs (Royal Marsden, HSL), academic and research institutions (Francis Crick Institute, Earlham Institute), CDMOs/CROs (Lonza, virology CROs running ELISA at scale), and public-sector organizations.

The company has raised approximately $135 million-plus across multiple rounds, including a $50M Series B in February 2022 led by Octopus Ventures, a $40M round in October 2023 led by Dimension with A.P. Moller Holding, and a $45M Series C in January 2026 led by Dimension with Danaher Ventures and a strategic investment partnership with Danaher Corporation — including integrations of LINQ into Molecular Devices and Beckman Coulter Life Sciences and a board seat for Danaher Ventures' Murali Venkatesan. A US presence has been built out through offices in Cambridge (Kendall Square) and Newton, MA, complementing the London UK headquarters, and the platform is now an ecosystem partner inside Benchling's Benchling Automation launch (May 2026).

Automata firmographics

Firmographics
Name
Automata
Legal name
Automata Technologies Limited
Website
https://automata.tech
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
101–250 employees
Short description
Automata is a London-based lab automation company selling the LINQ platform — vertically integrated modular robotic hardware, cloud orchestration software, and a no-code workflow designer — to pharmaceutical, biotech, NHS, academic, and CDMO/CRO customers to scale wet-lab throughput and enable AI-ready, closed-loop experimentation.
Ownership category
akta.pro rank

Automata industry classification

Industry
Product category
Lab Automation Platform
NAICS
Computer Systems Design and Related Services (54151), Computer Systems Design Services (541512)
SIC
Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)
akta.pro primary industry
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management) (HDAEANAA)
akta.pro secondary industries
AutoML & Low-Code ML Platform Operations (HDAAABAL), Model Development & Training Platforms (AutoML, Notebooks, Feature Stores) (HDAEANAB), Workflow Automation for IT & Ops (Runbooks, Job Scheduling) (HDAEAHAH)

Keywords

  • Lab automation platform
  • Robotic lab bench
  • Workflow orchestration software
  • Life sciences automation
  • AI-ready lab infrastructure

Where Automata is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices5 records

Markets served

Automata business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. LINQ Bench hardware sales: Sale and deployment of the proprietary modular robotic lab bench (LINQ Bench), a vertically integrated hardware product configurable to over 800,000 layouts. Sold as part of system deployments to life-sciences labs; underpins large capital sales engagements.
  2. LINQ Cloud software subscription: Recurring software revenue from the cloud-based LINQ orchestrator, providing workflow design, scheduling, version control, REST API integration, LIMS data exchange, and real-time run management. Bundled with deployments and sold as ongoing SaaS to pharma, biotech, NHS, and academic customers.
  3. Service, support and customer success: "Dedicated customer success managers' guidance at every stage. Customer success, NOT customer support." Covers installation, integration with third-party instruments, training, and ongoing service-level agreements, including dedicated hardware and software SLAs.
  4. Custom integration and application development: Professional services for bespoke workflow automation (e.g., deployment with the Francis Crick Institute's Advanced Sequencing Facility, "dedicated field application scientist and field application engineer working closely with laboratory scientists to optimise the deployment at every stage").

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based, not publicly disclosed

Go-to-market motion4 records

Distribution channels4 records

Marketing channels10 records

Automata product offering

Product offering

Core offering

Automata sells the LINQ platform, a software-defined lab automation system combining modular robotic hardware (LINQ Bench with 800,000+ configurations), cloud-based orchestration software (LINQ Cloud), and a node-based workflow design tool (LINQ Canvas with Python SDK). The platform enables life-sciences labs to parallelize workflows, integrate OEM-agnostic third-party instruments, and connect AI models via MCP for closed-loop experimentation.

Product overview

Automata offers a single unified lab automation platform called LINQ, structured as a platform-plus-modules architecture. The core LINQ platform is composed of three primary modules: LINQ Bench (proprietary configurable robotic hardware that fits in a standard lab bench footprint with over 800,000 customizable configurations), LINQ Cloud (cloud-based orchestration software with deep version control and remote access), and LINQ Canvas (node-based visual workflow design software requiring no coding). These modules are complemented by a Python SDK (developer experience tool that is seamlessly interchangeable with LINQ Canvas) and MCP-enabled connectivity to AI models. The platform is applied across three application verticals: Genomics (nucleic acid extraction, library prep, clinical genomics, quality control), Cell Biology (cell line development, media exchange, high-throughput screening, iPSC), and Assay & Screening (ELISA, cell-based assays). The platform is OEM-agnostic and integrates with existing lab instruments from multiple manufacturers, designed to be the operating system for AI-ready labs.

Differentiator

Problem solved

Functional benefit

Brands

  • LINQ: Automata's vertically integrated, software-defined lab automation platform comprising LINQ Bench (modular robotic lab bench hardware with over 800,000 configurable layouts), LINQ Cloud (cloud-based laboratory orchestration software), and LINQ Canvas (node-based workflow design tool with Python SDK).

Products and services

  • LINQ Platform A fully integrated, AI-ready lab automation platform that combines software, proprietary modular hardware, data availability, and an OEM-agnostic approach to enable modular configurations, higher throughputs, and parallel workflows for life-sciences labs.
  • LINQ Bench A configurable robotic lab bench that fits into the same footprint as a regular lab bench and supports any instrument with over 800,000 customizable configurations, including dual-access design and Bridge/Maglev transport options for seamless connections and high-speed transfers.
  • LINQ Cloud A cloud-based laboratory orchestrator that enables teams to build and test workflows as workcells process samples, with remote access, tags, runtime instructions, deep GitHub-synced version control, and the ability to run legacy versions on the latest platform.
  • LINQ Canvas A node-based workflow design software tool that lets scientists build complex experiments with no coding required, including High Fidelity Simulation, a Run Manager for real-time monitoring, and Process Canvas for full orchestration of multiple workflows simultaneously.
  • LINQ Python SDK A Python software development kit that lets developers control every step of LINQ workflow automation from setup to simulation on a digital workcell, seamlessly interchangeable with LINQ Canvas for code-based or visual workflow design.
  • Genomics Automation Solutions Application-specific automation solutions for genomics workflows covering nucleic acid extraction, automated library prep, clinical genomics, and quality control, supporting diverse sample types with open chemistry compatibility.
  • Cell Biology Automation Solutions Application-specific automation solutions for cell biology workflows including cell line development and cryopreservation, media exchange, high-throughput screening, and iPSC cell culture, handling suspension cells, adherent cells, and organoids.
  • Assay and Screening Automation Solutions Application-specific automation solutions for assay and screening workflows including ELISA and cell-based assays, with vendor-agnostic integration, cloud-based workflow orchestration, and enhanced data traceability via automated barcode scanning.

Quantifiable outcome

  • 95.25% reduction in manual interactions in a UK genomic testing lab's library preparation workflow
  • +7 more outcomes

Companies that use Automata

Customer profile

Named customers10 records

Segments7 records

Ideal customer profiles5 records

Automata technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration10 records

AI capability9 records

Feature7 records

Automata partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered flagship - global strategic partner, flagship - strategic integration partner, flagship - deep technical integration, core - ai co-development partner, flagship - r&d partnership, flagship - flagship clinical reference, core - ecosystem partner, core - cell biology reference partner and core - genomics reference partner.

  • Danaher Corporationflagship - global strategic partnerStrategic or Co-development PartnerGlobal life sciences tools conglomerate. Entered a strategic investment partnership alongside the Series C that integrates Automata's software with Danaher's portfolio of instruments and reagents, including Molecular Devices and Beckman Coulter Life Sciences, to deliver end-to-end lab automation solutions.
  • Beckman Coulter Life Sciencesflagship - strategic integration partnerStrategic or Co-development PartnerSubsidiary of Danaher. Strategic partnership to integrate Beckman Coulter's liquid handling, genomic and cell analysis technologies with Automata's LINQ AI-ready automation platform, enabling faster and more scalable experimentation. The collaboration coincides with Danaher Ventures' Series C participation and a board seat.
  • Molecular Devicesflagship - deep technical integrationTechnology or IntegrationDanaher subsidiary. Strategic collaboration announced 29 January 2026 to integrate Molecular Devices' microplate readers and high-content screening systems with Automata's LINQ platform, enabling lab instruments from different brands to communicate and move samples via software and robotics without human intervention.
  • CellVoyantcore - ai co-development partnerStrategic or Co-development PartnerAI biotech startup. Strategic partnership to deliver AI-powered closed-loop cell culture workflows by combining CellVoyant's AI with Automata's LINQ platform, making "adaptive cell culture an operational reality" (quote from CellVoyant Founder/CEO Rafael E. Carazo Salas).
  • The Francis Crick Instituteflagship - r&d partnershipStrategic or Co-development PartnerBiomedical discovery institute. Announced 13 February 2023, Automata partners with the Crick's Advanced Sequencing Facility to automate three genomics workflows (amplicon library prep, FFPE RNA extraction, COVID-19 sequencing). The Crick enjoys early access to Automata demos and is a key stakeholder in product development.
  • The Royal Marsden NHS Foundation Trustflagship - flagship clinical referenceStrategic or Co-development PartnerUK cancer centre. Partnership for a UK-first clinical diagnostics installation of Automata's robotic technology to "transform genomic testing at The Royal Marsden by streamlining our processes, substantially increasing our capacity without compromising accuracy" (Professor Michael Hubank, Scientific Director of Clinical Genomics).
  • Benchlingcore - ecosystem partnerTechnology or IntegrationLaunched Benchling Automation on 28 May 2026 with ecosystem partners including HighRes, Automata, Ginkgo Bioworks, Celltrio, Opentrons, and Hamilton - a hardware-agnostic platform connecting lab instruments, workcells, and scientific records. Automata's LINQ workcells are callable from Benchling notebooks.
  • bit.biocore - cell biology reference partnerStrategic or Co-development PartnerSynthetic biology company. Listed as a partner/customer in Automata's "Trusted by our partners" logo strip and named in the 2023 $40m round press release.
  • Earlham Institutecore - genomics reference partnerStrategic or Co-development PartnerGenomics research institute. Partnership to "redefine lab automation" and "transform QC into a scalable genomics engine" (case study title on the website).

Scale indicators11 records

Recent moves7 records

Expansion highlights7 records

Automata competitors and assessment

Company assessment

Direct peers

  • Opentrons: Opentrons builds accessible benchtop lab robots (OT-2, Flex) with a Python API and a workflow/automation software stack, targeting biotech and academic labs with a similar modular, software-first ethos to Automata's LINQ. Listed alongside Automata as a Benchling Automation ecosystem partner, indicating direct overlap in customer use cases.
  • HighRes Biosolutions: HighRes Biosolutions offers modular lab automation systems (Cellario software, modular robotic workstations) for pharma, biotech, and academic labs - the closest head-to-head competitor to Automata's LINQ Bench + LINQ Cloud platform. Co-listed with Automata in the Benchling Automation ecosystem.
  • Biosero: Biosero offers Green Button Go, a laboratory automation scheduling and orchestration software that connects instruments, robots, and LIMS - directly comparable to LINQ Cloud's orchestration role, with a similar 'software over hardware' positioning.

Broad incumbents

  • Hamilton Company: Hamilton is a long-established leader in automated liquid handling workstations and lab robotics (Microlab STAR, VANTAGE) with a deep pharma/biotech installed base and integrated software. Competes with Automata on enterprise lab automation and is co-listed in the Benchling Automation ecosystem.
  • Tecan: Tecan is a major incumbent in laboratory automation, offering liquid handling platforms, readers, and workflow software used across pharma, biotech, and diagnostics. Overlaps with Automata's genomics and cell biology workflows and has the scale to bundle software with its installed base.
  • Beckman Coulter Life Sciences: Beckman Coulter Life Sciences (a Danaher subsidiary) provides liquid handlers, genomic and cell-analysis instruments that integrate with Automata's LINQ platform via a strategic partnership. It is both a distribution partner and a competitor in lab automation hardware.
  • Thermo Fisher Scientific: Thermo Fisher offers the largest portfolio of life-sciences instruments and automation products (e.g., Orbitor, Spinnaker) along with software for lab workflows. Its scale, breadth, and service network represent the highest-end incumbent competition to Automata.
  • Agilent Technologies: Agilent's Bravo liquid handler is explicitly integrated within Automata's open NGS library preparation workflows, and the company provides broader lab automation and analytical instruments. Comparable to Automata in genomics and analytical workflow automation.

Emerging players

  • Celltrio: Celltrio provides cell-line development and cell therapy automation platforms (e.g., RoboQ, CellPicker) with software for closed-loop cell culture - a closely adjacent emerging player to Automata, particularly in the cell biology application vertical, and co-listed in Benchling Automation.

Others

  • Ginkgo Bioworks: Ginkgo Bioworks operates large-scale automated synthetic biology foundries with proprietary software/hardware stacks for high-throughput organism engineering. While a buyer/integrator rather than direct vendor competitor, it is a comparable 'automated lab at scale' reference and is co-listed in Benchling Automation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Automata social profiles

Digital presence

Automata compliance and trust

Trust signal

Compliance3 records

Automata financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Automata leadership team

Management profile

Number of profiles

Profiles11 records

Automata subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Automata funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors19 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Automata M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Automata

What does Automata do?

Automata sells the LINQ platform, a software-defined lab automation system combining modular robotic hardware (LINQ Bench with 800,000+ configurations), cloud-based orchestration software (LINQ Cloud), and a node-based workflow design tool (LINQ Canvas with Python SDK). The platform enables life-sciences labs to parallelize workflows, integrate OEM-agnostic third-party instruments, and connect AI models via MCP for closed-loop experimentation.

Is Automata a public or private company?

Automata is a private company. It is classified as venture growth investor backed and is currently operating.

When was Automata founded?

Automata was founded in 2015. It employs 101 to 250 people.

Where is Automata based?

Automata is headquartered in London, United Kingdom, in the Europe region.

How does Automata make money?

Four revenue lines are on record. LINQ Bench hardware sales are the primary driver. The others are LINQ Cloud software subscription, service, support and customer success and custom integration and application development.

Who are Automata's main competitors?

Direct peers on record are Opentrons, HighRes Biosolutions and Biosero. Broad incumbents are Hamilton Company, Tecan, Beckman Coulter Life Sciences, Thermo Fisher Scientific and Agilent Technologies. Celltrio is listed as an emerging player. Ginkgo Bioworks is listed as an others.

Does Automata have an API?

Yes. Automata's LINQ platform offers a Python SDK that allows developers to control every step from setup to simulation on a digital workcell. The SDK is seamlessly interchangeable with LINQ Canvas, the no-code workflow builder. The platform exposes a REST API enabling custom code steps for seamless integration with external systems, supporting in-workflow data processing and transformation. Additionally, LINQ features MCP-enabled (Model Context Protocol) connectivity that connects LINQ to AI models, allowing AI systems to design and orchestrate experiments. Deep version control allows users to sync with GitHub and run legacy versions on the latest platform. Developer documentation is at www.automata.tech/linq-documentation.

What industry is Automata in?

Automata's product category is Lab Automation Platform. Its primary akta.pro industry code is HDAEANAA, End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management), with a secondary code of HDAAABAL, AutoML & Low-Code ML Platform Operations. Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
UKTNRobotics funding for 2026 reaches almost £190m as Cambridge leads the wayA Tracxn report found UK robotics firms raised $258m (£189.3m) across 12 rounds in 2026 so far, up from $150m (£110m) in 2025, with Humanoid's $152m Series A and Automata's $45m Series C accounting for 76% of the total. Cambridge led with $1.3bn (£954m) across 13 rounds, ahead of London's $582m.Intelligent CIOUK Robotics funding reaches US$258m as Cambridge leads investment – Intelligent CIO EuropeTracxn Technologies reported that UK robotics companies raised US$258 million year-to-date in 2026, a significant increase from the previous year's total. This surge was primarily driven by two major funding rounds: Humanoid's US$152 million Series A and Automata's US$45 million Series C. The data indicates that investment capital is becoming increasingly concentrated among a few large deals and specific geographic hubs like Cambridge.FinancialContent Business PageEckuity Capital Launches Fund II and Backs Automata TechnologiesEckuity Capital announced the first close of its Fund II and the fund's inaugural investment, leading the Series C round of Automata Technologies alongside Danaher, a global science and technology leader. Automata uses artificial intelligence to automate laboratory operations for life sciences and diagnostics organizations. The fund build on Eckuity's first fund, which is fully deployed across 14 high-growth life sciences companies, with the firm planning to continue building its Fund II portfolio through the year.YahooEckuity Capital Launches Fund II and Backs Automata TechnologiesEckuity Capital announced the first close of Fund II and its inaugural investment, leading Automata Technologies' Series C alongside Danaher. The fund builds on a first fund deployed across 14 companies, and Eckuity will continue building the portfolio through the year.BioSpaceEckuity Capital Launches Fund II and Backs Automata TechnologiesEckuity Capital announced the first close of its Fund II and its inaugural investment, leading Automata Technologies' Series C alongside Danaher. The fund builds on a first fund fully deployed across 14 companies, and Eckuity will continue building the portfolio through the year.GlobeNewswireAnnual report and financial statements for the year ended 31 December 2025Octopus Titan VCT reported a -10.9% total return for the year ended 31 December 2025, with net assets falling to £733 million. The company paid no dividend and did not meet its performance guardrails, citing limited realisations. The board will monitor progress against guardrails in 2026.Platum오토메타, 시리즈 A 105억 원 유치…온톨로지 기반 AI 엔터프라이즈 플랫폼 ‘Zenith AI’ 고도화Autometa raised 10.5 billion won in Series A funding from six investors. The company's Zenith AI platform automates software development using an ontology-based engine, having worked with over 80 companies across seven countries for eight years. It plans to expand enterprise applications and enter the global market.DrugdiscoverytrendsSLAS 2026: Orchestration patforms, API-first instruments and the rise of semiautonomous labsSLAS 2026 in Boston showcased a major industry shift toward AI-enabled laboratory automation, with 15 orchestration platforms competing to become the operating system layer for closed-loop labs. OpenAI and Ginkgo Bioworks demonstrated the most significant advancement by running 36,000 protein synthesis experiments autonomously with GPT-5, reducing sfGFP production costs by roughly 40%. The conference also featured Automata's $45M Series C funding, multiple product launches from Biosero, QIAGEN, Cenevo, and ABB, and a survey revealing that 45% of scientists use unauthorized AI tools due to inadequate official platforms.RdworldonlineAutomata raises $45M to scale lab automation platform, adds Danaher as strategic investorLondon-based Automata has closed a $45 million Series C funding round led by Dimension, with participation from Danaher Ventures, making Danaher Corporation a strategic investment partner alongside other investors including Tru Arrow Partners, Octopus Ventures, and Entrepreneurs First. As part of the deal, Danaher portfolio companies Molecular Devices and Beckman Coulter Life Sciences will integrate their liquid handling, genomic and cell analysis technologies with Automata's LINQ lab automation platform, and Danaher Ventures' Murali Venkatesan will join Automata's board. The funding will accelerate global deployment of the LINQ platform, development of closed-loop experimentation software, and expansion of Automata's engineering, product, and customer success teams.RdworldonlineMolecular Devices and Automata partner to connect lab instrumentsMolecular Devices, a Danaher Corporation company, has announced a strategic collaboration with London-based Automata to integrate its imaging systems and microplate readers with Automata's LINQ platform, enabling lab instruments from different brands to communicate and move samples via software and robotics without human intervention. Danaher Ventures participated in Automata's Series C funding round and secured a board seat as part of the deal, while Beckman Coulter Life Sciences, another Danaher company, is also integrating its instruments with the LINQ platform to create a unified ecosystem across multiple Danaher life sciences brands. The collaboration aims to eliminate manual bottlenecks in research workflows that introduce variability and potential error when scientists manually move plates between instruments.